← Back to Search

Attention Control Training for Anxiety

N/A

Waitlist Available

Research Sponsored by Northern Illinois University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age at least 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 0 (online baseline survey), day 7, and one month follow-up (week 5)

Awards & highlights

Study Summary

This trial will test whether a self-administered brief neurobehavioral intervention (ATT) to increase attentional control will decrease acute fear responding, and whether this change is associated with increased ability to handle attentional interference.

Who is the study for?

This trial is for adults over 18, fluent in English, enrolled at Northern Illinois University with elevated symptoms of fear-based disorders like PTSD or panic. They must have slower reaction times on a specific attention task and own a smartphone. Those with ADHD, auditory/visual impairments, or active psychotic symptoms cannot participate.Check my eligibility

What is being tested?

The study tests if the Attention Training Technique (ATT), a neurobehavioral intervention aimed at improving attention control, can reduce acute fear responses compared to a sham intervention. Participants' ability to handle distractions and their reported fear levels are measured throughout.See study design

What are the potential side effects?

As ATT is a psychological training technique rather than medication, it may not have traditional side effects but could potentially cause temporary increases in anxiety or discomfort due to focusing on attention tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 0 (online baseline survey), day 7, and one month follow-up (week 5)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 0 (online baseline survey), day 7, and one month follow-up (week 5)

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 (online baseline survey), day 7, and one month follow-up (week 5) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Acute Fear Response (i.e., Fear Load and Fear Inhibition) at Post-intervention

Change in Attention Network Task(ANT)/Attentional Control Efficiency at Post-intervention

Change in Self-Reported Attentional Control:. Attentional Control Scale, Short form (ACS-S; Judah et al., 2014)

+2 more

Secondary outcome measures

Change in Circumscribed Fear Measure, Most Feared (CFM-MF; McCraw & Valentiner, 2015)

Change in PTSD Checklist for DSM-5 (PCL-5; Weathers et al., 2013)

Panic Disorder

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Attention Training Technique (ATT)Experimental Treatment1 Intervention

Group II: Sham intervention control conditionActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Attention Training Technique

2015

N/A

~110

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Northern Illinois UniversityLead Sponsor

8 Previous Clinical Trials

650 Total Patients Enrolled

Media Library

Attention Training Technique Clinical Trial Eligibility Overview. Trial Name: NCT04080115 — N/A

Attention Deficit Disorder Research Study Groups: Attention Training Technique (ATT), Sham intervention control condition

Attention Deficit Disorder Clinical Trial 2023: Attention Training Technique Highlights & Side Effects. Trial Name: NCT04080115 — N/A

Attention Training Technique 2023 Treatment Timeline for Medical Study. Trial Name: NCT04080115 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the ambition of this experiment?

"The purpose of this research initiative, which will be evaluated on Day 1 (Baseline/pre-intervention) and Day 7 (Post-intervention), is to measure the transformation in Attention Network Task(ANT)/Attentional Control Efficiency at Post-intervention. Moreover, secondary objectives include examining the variation in Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998), PTSD Checklist for DSM-5 (PCL-5; Weathers et al., 2013), and Circumscribed Fear Measure, Most Feared (CFM-MF; McCraw & Valentiner, 2015)."

Answered by AI

Is there capacity for additional participants in this trial?

"Data from clinicaltrials.gov indicates that this particular trial, which was initially published on October 15th 2021 and last edited on September 9th 2022, is not recruiting any new patients at the moment. Fortunately, there are 20 other ongoing trials actively looking for participants right now."

Answered by AI